Biotia

This year has brought a surge in dengue across the world associated with higher temperatures. Another reminder it is essential to track these threats across nations and model drivers of infections.

🔬Happy Global City Sampling Day! 🌎 Today, hundreds of scientists, researchers, and citizen volunteers are collecting samples from public spaces – subways, buses, airports, and more – across the globe. This data will create a genetic and epigenetic map of the diverse microbiomes in our cities. Want to see the magic happen in real time? Check out the interactive map on GeoSeeq. Follow the sampling efforts as they unfold, revealing where samples are being collected and stay tuned to see the results of how humans interact with the microbial world within cities. #GlobalCitySamplingDay #MetaSUB #GeoSeeq https://lnkd.in/e-wD_Hwy

Excited to share that our CMO, Dr. Dorottya Nagy-Szakal MD PhD and Director of R&D, Mara Couto-Rodriguez, are representing Biotia at American Society for Microbiology 2024 in NYC this week! If you're attending #ASMMicrobeNYC, be sure to stop by our booth to say hello and learn more about how Biotia is advancing the field of clinical microbiology and molecular diagnostics of infectious diseases. #ASMMicrobe #Microbiology #Biotia #Metagenomics

We are excited to share that our CEO and cofounder, Dr. Niamh B. O'Hara, will be speaking at Cornell Tech's HealthNext Summit. Join her at 1:50 PM ET on March 4th to hear about Biotia's work. #HealthNext2024 https://lnkd.in/eQRu9fja

Our CEO and cofounder, Dr. Niamh B. O'Hara, will be participating in the HealthNext Summit 2024 at Cornell Tech's Roosevelt Island campus in New York. This fantastic event brings together researchers, industry professionals, and stakeholders with a focus on exploring AI applications in healthcare. If you're attending, don't miss her lightning talk at 1:50 PM ET on March 4th.

Yesterday our CEO and cofounder, Dr. Niamh B. O'Hara attended a breakfast at Cornell Tech with Former NYC Mayor Mike Bloomberg. What an honor it was to sit with other startups and chat about the work we're doing. Thank you for the opportunity!

Great article about the potential of environmental DNA (eDNA) for disease surveillance! This innovative approach uses genetic material collected from the environment to track the spread of pathogens, potentially allowing us to stop outbreaks before they cause widespread harm. Geoseeq (thanks for the shoutout), the platform hosting Dr. Christopher Mason's lab MetaSub data, is at the forefront of eDNA analysis, monitoring for pathogens in wastewater, helping communities stay ahead of potential outbreaks. This is a game-changer for public health, and we are excited to see how eDNA technology continues to develop. And if you're interested in learning more about Geoseeq's work, check out our website! www.geoseeq.com #eDNA #PublicHealth #Geoseeq #FutureofHealthcare

Our CEO, Dr. Niamh B. O'Hara and Head of Business Development, Dr. Michael Benzinou will be sharing their expertise at the #AGU23 conference today, both virtually and in-person, alongside Dr. Charlie Vorosmarty, Dr. Angela Rasmussen, and Rick Lawford. Together, they will be discussing how valuable interdisciplinary collaborations can augment insights around climate-sensitive infectious diseases. Session details for those who are attending: Title: Town Hall TH33D: The Role of Earth System Science Data and Frameworks in an Early Warning System for Global Pandemics When: Wednesday December 13th 2023 13:00 - 14:00 PST in the Moscone Center, Room: 2016 – West, or online for those joining remotely.

Our Chief Medical Officer, Dorottya Nagy-Szakal MD PhD, is currently attending #PNAM2023 in Tunis! What an honor it is to be a part of such a special and important event.

Our CEO, Dr. Niamh B. O'Hara, is currently attending the Milken Institute #FutureofHealthSummit2023 in DC. On a inspiring panel, Dr. Susan Coller Monarez, Ph.D., Deputy Director, ARPA-H, spoke about how Advanced Research Projects Agency for Health (ARPA-H) was formed to make groundbreaking advancements and innovative solutions in healthcare in gaps not currently being addressed. One of the key focuses, as for Biotia, is on Antimicrobial Resistance (AMR) in their #DARTS program. Reach out if you are at #Milken and want to connect! #MilkenInstitute #HealthSummit2023